MP48-03 TRACKING, TARGETING, AND DE NOVO TUMOR DEVELOPMENT IN MEN UNDERGOING ACTIVE SURVEILLANCE Article Swipe

PDF

Rajiv Jayadevan , Danielle Barsa , Haoyue Zhang , Lorna Kwan , Steve Zhou , Alan Priester , Jorge Ballon , Leonard Marks ·

YOU? · · 2019 · Open Access · · DOI: https://doi.org/10.1097/01.ju.0000556473.69506.25

You have accessJournal of UrologyProstate Cancer: Localized: Active Surveillance I (MP48)1 Apr 2019MP48-03 TRACKING, TARGETING, AND DE NOVO TUMOR DEVELOPMENT IN MEN UNDERGOING ACTIVE SURVEILLANCE Rajiv Jayadevan*, Danielle Barsa, Haoyue Zhang, Lorna Kwan, Steve Zhou, Alan Priester, Jorge Ballon, and Leonard Marks Rajiv Jayadevan*Rajiv Jayadevan* More articles by this author , Danielle BarsaDanielle Barsa More articles by this author , Haoyue ZhangHaoyue Zhang More articles by this author , Lorna KwanLorna Kwan More articles by this author , Steve ZhouSteve Zhou More articles by this author , Alan PriesterAlan Priester More articles by this author , Jorge BallonJorge Ballon More articles by this author , and Leonard MarksLeonard Marks More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000556473.69506.25AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Tracking biopsy is the resampling of previously-documented site(s) of intra-prostatic tumor (CaP). Precise resampling is enabled via electronic storage of specific biopsy sites during MRI-ultrasound fusion biopsy (FB) for future recall. Though tracking can aid in surveillance of specific biopsy sites, it is possible for de novo tumors to develop in other regions of the prostate during active surveillance (AS). We sought to determine the cancer upgrading rate in tracked and non-tracked biopsies, and also to ascertain the frequency of de novo tumor development in a large sample of men undergoing AS. METHODS: Men diagnosed with Gleason Grade Group (GG) 1 CaP between 2009 and 2017 were offered AS. Multiparametric MRI and FB were performed every 12-18 months. All confirmatory biopsies (CB) and follow-up biopsies were performed using a FB system (Artemis). Systematic biopsy was also performed during all biopsy sessions. Sites that were positive for cancer on prior biopsies were resampled via tracking biopsy (Fig 1). Pathologic upgrading was defined as change from GG1 to GG2 or greater. MRIs were reviewed for the development of new regions of interest (ROI). RESULTS: 168 men had GG1 CaP on both diagnostic and CB, underwent at least 1 follow-up biopsy, and had both tracked and non-tracked biopsies during the same biopsy session (mean age 62.1, prostate specific antigen 4.8 ng/mL, median follow-up time 4.1 years). Of this group, 38% (n=63) were found to have pathologic upgrading to at least GG2 disease. 46% (n=29) of upgrading was detected via tracked biopsy only, 41% (n=26) detected via non-tracked biopsy only, and 13% (n=8) detected via both biopsy types. Of men whose upgrades were detected via only non-tracked biopsy, 35% (n=9) were detected via systematic biopsy, 65% (n=15) via targeted FB, and 8% (n=2) via both. 35% (n=9) of these upgrades appear to be de novo tumors, as upgrading foci were either contralateral to sites of known GG1 tumors (n=3), or found within newly detected ROIs seen on subsequent MRI. Median time from start of AS to development of new ROI containing upgrade was 2.1 years. CONCLUSIONS: Tracking biopsy detects a large percentage of pathologic upgrading for men on AS. Serial MRI and systematic biopsy during AS may detect de novo tumors. Both tracked and non-tracked biopsies are additive in the detection of pathologic upgrading and de novo tumors. Source of Funding: Supported in part by R01 grants CA158627, CA218547, and CA195505 Los Angeles, CA© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e697-e697 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Rajiv Jayadevan* More articles by this author Danielle Barsa More articles by this author Haoyue Zhang More articles by this author Lorna Kwan More articles by this author Steve Zhou More articles by this author Alan Priester More articles by this author Jorge Ballon More articles by this author Leonard Marks More articles by this author Expand All Advertisement PDF downloadLoading ...

Related Topics

Concepts

Medicine Biopsy Prostate cancer Cancer Surgery Radiology Internal medicine

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1097/01.ju.0000556473.69506.25
PDF: https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556473.69506.25
OA Status: bronze
Related Works: 10
OpenAlex ID: https://openalex.org/W2942330876

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W2942330876

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1097/01.ju.0000556473.69506.25

Digital Object Identifier
Title: MP48-03 TRACKING, TARGETING, AND DE NOVO TUMOR DEVELOPMENT IN MEN UNDERGOING ACTIVE SURVEILLANCE

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2019

Year of publication
Publication date: 2019-04-01

Full publication date if available
Authors: Rajiv Jayadevan, Danielle Barsa, Haoyue Zhang, Lorna Kwan, Steve Zhou, Alan Priester, Jorge Ballon, Leonard Marks

List of authors in order
Landing page: https://doi.org/10.1097/01.ju.0000556473.69506.25

Publisher landing page
PDF URL: https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556473.69506.25

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556473.69506.25

Direct OA link when available
Concepts: Medicine, Biopsy, Prostate cancer, Cancer, Surgery, Radiology, Internal medicine

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W2942330876
doi	https://doi.org/10.1097/01.ju.0000556473.69506.25
ids.doi	https://doi.org/10.1097/01.ju.0000556473.69506.25
ids.mag	2942330876
ids.openalex	https://openalex.org/W2942330876
fwci	0.0
type	article
title	MP48-03 TRACKING, TARGETING, AND DE NOVO TUMOR DEVELOPMENT IN MEN UNDERGOING ACTIVE SURVEILLANCE
biblio.issue	Supplement 4
biblio.volume	201
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10124
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9921000003814697
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2740
topics[0].subfield.display_name	Pulmonary and Respiratory Medicine
topics[0].display_name	Prostate Cancer Diagnosis and Treatment
topics[1].id	https://openalex.org/T12422
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9284999966621399
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2741
topics[1].subfield.display_name	Radiology, Nuclear Medicine and Imaging
topics[1].display_name	Radiomics and Machine Learning in Medical Imaging
topics[2].id	https://openalex.org/T10543
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9036999940872192
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2740
topics[2].subfield.display_name	Pulmonary and Respiratory Medicine
topics[2].display_name	Prostate Cancer Treatment and Research
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.8790419697761536
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C2775934546
concepts[1].level	2
concepts[1].score	0.6368177533149719
concepts[1].wikidata	https://www.wikidata.org/wiki/Q179991
concepts[1].display_name	Biopsy
concepts[2].id	https://openalex.org/C2780192828
concepts[2].level	3
concepts[2].score	0.6043339371681213
concepts[2].wikidata	https://www.wikidata.org/wiki/Q181257
concepts[2].display_name	Prostate cancer
concepts[3].id	https://openalex.org/C121608353
concepts[3].level	2
concepts[3].score	0.4304870367050171
concepts[3].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[3].display_name	Cancer
concepts[4].id	https://openalex.org/C141071460
concepts[4].level	1
concepts[4].score	0.3270198702812195
concepts[4].wikidata	https://www.wikidata.org/wiki/Q40821
concepts[4].display_name	Surgery
concepts[5].id	https://openalex.org/C126838900
concepts[5].level	1
concepts[5].score	0.24748337268829346
concepts[5].wikidata	https://www.wikidata.org/wiki/Q77604
concepts[5].display_name	Radiology
concepts[6].id	https://openalex.org/C126322002
concepts[6].level	1
concepts[6].score	0.16888293623924255
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[6].display_name	Internal medicine
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.8790419697761536
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/biopsy
keywords[1].score	0.6368177533149719
keywords[1].display_name	Biopsy
keywords[2].id	https://openalex.org/keywords/prostate-cancer
keywords[2].score	0.6043339371681213
keywords[2].display_name	Prostate cancer
keywords[3].id	https://openalex.org/keywords/cancer
keywords[3].score	0.4304870367050171
keywords[3].display_name	Cancer
keywords[4].id	https://openalex.org/keywords/surgery
keywords[4].score	0.3270198702812195
keywords[4].display_name	Surgery
keywords[5].id	https://openalex.org/keywords/radiology
keywords[5].score	0.24748337268829346
keywords[5].display_name	Radiology
keywords[6].id	https://openalex.org/keywords/internal-medicine
keywords[6].score	0.16888293623924255
keywords[6].display_name	Internal medicine
language	en
locations[0].id	doi:10.1097/01.ju.0000556473.69506.25
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S30525748
locations[0].source.issn	0022-5347, 1527-3792
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0022-5347
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	The Journal of Urology
locations[0].source.host_organization	https://openalex.org/P4310315671
locations[0].source.host_organization_name	Lippincott Williams & Wilkins
locations[0].source.host_organization_lineage	https://openalex.org/P4310315671
locations[0].license
locations[0].pdf_url	https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556473.69506.25
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Journal of Urology
locations[0].landing_page_url	https://doi.org/10.1097/01.ju.0000556473.69506.25
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5075614301
authorships[0].author.orcid	https://orcid.org/0000-0002-8408-8905
authorships[0].author.display_name	Rajiv Jayadevan
authorships[0].affiliations[0].raw_affiliation_string	Los Angeles, CA
authorships[0].author_position	first
authorships[0].raw_author_name	Rajiv Jayadevan*
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Los Angeles, CA
authorships[1].author.id	https://openalex.org/A5065118641
authorships[1].author.orcid
authorships[1].author.display_name	Danielle Barsa
authorships[1].affiliations[0].raw_affiliation_string	Los Angeles, CA
authorships[1].author_position	middle
authorships[1].raw_author_name	Danielle Barsa
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Los Angeles, CA
authorships[2].author.id	https://openalex.org/A5006645827
authorships[2].author.orcid	https://orcid.org/0000-0002-9412-7584
authorships[2].author.display_name	Haoyue Zhang
authorships[2].affiliations[0].raw_affiliation_string	Los Angeles, CA
authorships[2].author_position	middle
authorships[2].raw_author_name	Haoyue Zhang
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Los Angeles, CA
authorships[3].author.id	https://openalex.org/A5054715759
authorships[3].author.orcid
authorships[3].author.display_name	Lorna Kwan
authorships[3].affiliations[0].raw_affiliation_string	Los Angeles, CA
authorships[3].author_position	middle
authorships[3].raw_author_name	Lorna Kwan
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Los Angeles, CA
authorships[4].author.id	https://openalex.org/A5017602024
authorships[4].author.orcid	https://orcid.org/0000-0003-1169-8072
authorships[4].author.display_name	Steve Zhou
authorships[4].affiliations[0].raw_affiliation_string	Los Angeles, CA
authorships[4].author_position	middle
authorships[4].raw_author_name	Steve Zhou
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Los Angeles, CA
authorships[5].author.id	https://openalex.org/A5071325999
authorships[5].author.orcid	https://orcid.org/0000-0001-9188-5905
authorships[5].author.display_name	Alan Priester
authorships[5].affiliations[0].raw_affiliation_string	Los Angeles, CA
authorships[5].author_position	middle
authorships[5].raw_author_name	Alan Priester
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Los Angeles, CA
authorships[6].author.id	https://openalex.org/A5110974093
authorships[6].author.orcid
authorships[6].author.display_name	Jorge Ballon
authorships[6].affiliations[0].raw_affiliation_string	Los Angeles, CA
authorships[6].author_position	middle
authorships[6].raw_author_name	Jorge Ballon
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Los Angeles, CA
authorships[7].author.id	https://openalex.org/A5112208593
authorships[7].author.orcid
authorships[7].author.display_name	Leonard Marks
authorships[7].affiliations[0].raw_affiliation_string	Los Angeles, CA
authorships[7].author_position	last
authorships[7].raw_author_name	Leonard Marks
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Los Angeles, CA
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556473.69506.25
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	MP48-03 TRACKING, TARGETING, AND DE NOVO TUMOR DEVELOPMENT IN MEN UNDERGOING ACTIVE SURVEILLANCE
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10124
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9921000003814697
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2740
primary_topic.subfield.display_name	Pulmonary and Respiratory Medicine
primary_topic.display_name	Prostate Cancer Diagnosis and Treatment
related_works	https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W2586801360, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1097/01.ju.0000556473.69506.25
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S30525748
best_oa_location.source.issn	0022-5347, 1527-3792
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0022-5347
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	The Journal of Urology
best_oa_location.source.host_organization	https://openalex.org/P4310315671
best_oa_location.source.host_organization_name	Lippincott Williams & Wilkins
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310315671
best_oa_location.license
best_oa_location.pdf_url	https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556473.69506.25
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Journal of Urology
best_oa_location.landing_page_url	https://doi.org/10.1097/01.ju.0000556473.69506.25
primary_location.id	doi:10.1097/01.ju.0000556473.69506.25
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S30525748
primary_location.source.issn	0022-5347, 1527-3792
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0022-5347
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	The Journal of Urology
primary_location.source.host_organization	https://openalex.org/P4310315671
primary_location.source.host_organization_name	Lippincott Williams & Wilkins
primary_location.source.host_organization_lineage	https://openalex.org/P4310315671
primary_location.license
primary_location.pdf_url	https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556473.69506.25
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Journal of Urology
primary_location.landing_page_url	https://doi.org/10.1097/01.ju.0000556473.69506.25
publication_date	2019-04-01
publication_year	2019
referenced_works_count	0
abstract_inverted_index.&	546
abstract_inverted_index.,	50, 59, 68, 77, 86, 95, 104
abstract_inverted_index.1	229, 324
abstract_inverted_index.I	9
abstract_inverted_index.a	214, 257, 474
abstract_inverted_index.8%	416
abstract_inverted_index.AS	459, 490
abstract_inverted_index.DE	16
abstract_inverted_index.FB	241, 258
abstract_inverted_index.IN	20
abstract_inverted_index.Of	352, 393
abstract_inverted_index.We	189
abstract_inverted_index.as	290, 431
abstract_inverted_index.at	322, 364
abstract_inverted_index.be	427
abstract_inverted_index.by	47, 56, 65, 74, 83, 92, 101, 111, 519, 530, 549, 562, 569, 576, 583, 590, 597, 604, 611
abstract_inverted_index.de	174, 209, 428, 493, 510
abstract_inverted_index.in	164, 179, 197, 213, 503, 517
abstract_inverted_index.is	131, 143, 171
abstract_inverted_index.it	170
abstract_inverted_index.of	3, 134, 137, 148, 166, 182, 208, 217, 304, 307, 370, 422, 439, 458, 462, 477, 506, 514
abstract_inverted_index.on	276, 316, 451, 482
abstract_inverted_index.or	296, 444
abstract_inverted_index.to	119, 177, 191, 204, 294, 359, 363, 426, 437, 460
abstract_inverted_index....	619
abstract_inverted_index.1).	285
abstract_inverted_index.13%	386
abstract_inverted_index.168	311
abstract_inverted_index.2.1	468
abstract_inverted_index.35%	403, 420
abstract_inverted_index.38%	355
abstract_inverted_index.4.1	350
abstract_inverted_index.4.8	345
abstract_inverted_index.41%	378
abstract_inverted_index.46%	368
abstract_inverted_index.65%	410
abstract_inverted_index.AND	15, 127
abstract_inverted_index.AS.	220, 237, 483
abstract_inverted_index.All	115, 247, 615
abstract_inverted_index.Apr	11
abstract_inverted_index.CB,	320
abstract_inverted_index.CaP	230, 315
abstract_inverted_index.FB,	414
abstract_inverted_index.GG1	293, 314, 441
abstract_inverted_index.GG2	295, 366
abstract_inverted_index.Los	526
abstract_inverted_index.MEN	21
abstract_inverted_index.MRI	239, 485
abstract_inverted_index.Men	222
abstract_inverted_index.PDF	617
abstract_inverted_index.R01	520
abstract_inverted_index.ROI	464
abstract_inverted_index.You	0
abstract_inverted_index.age	340
abstract_inverted_index.aid	163
abstract_inverted_index.all	267
abstract_inverted_index.and	39, 105, 199, 202, 233, 240, 251, 319, 327, 331, 385, 415, 486, 498, 509, 524, 535, 554
abstract_inverted_index.are	501
abstract_inverted_index.can	162
abstract_inverted_index.for	157, 173, 274, 301, 480
abstract_inverted_index.had	313, 328
abstract_inverted_index.may	491
abstract_inverted_index.men	218, 312, 394, 481
abstract_inverted_index.new	305, 463
abstract_inverted_index.the	132, 183, 193, 206, 302, 335, 504
abstract_inverted_index.via	145, 281, 374, 381, 389, 399, 407, 412, 418
abstract_inverted_index.was	263, 288, 372, 467
abstract_inverted_index.(CB)	250
abstract_inverted_index.(FB)	156
abstract_inverted_index.(Fig	284
abstract_inverted_index.(GG)	228
abstract_inverted_index.2009	232
abstract_inverted_index.2017	234
abstract_inverted_index.2019	529, 548
abstract_inverted_index.Alan	35, 87, 593
abstract_inverted_index.Both	496
abstract_inverted_index.CA©	528
abstract_inverted_index.Kwan	71, 580
abstract_inverted_index.MRI.	453
abstract_inverted_index.MRIs	298
abstract_inverted_index.More	45, 54, 63, 72, 81, 90, 99, 109, 560, 567, 574, 581, 588, 595, 602, 609
abstract_inverted_index.NOVO	17
abstract_inverted_index.ROIs	449
abstract_inverted_index.View	114
abstract_inverted_index.Zhou	80, 587
abstract_inverted_index.also	203, 264
abstract_inverted_index.both	317, 329, 390
abstract_inverted_index.foci	433
abstract_inverted_index.from	292, 456
abstract_inverted_index.have	1, 360
abstract_inverted_index.novo	175, 210, 429, 494, 511
abstract_inverted_index.only	400
abstract_inverted_index.part	518
abstract_inverted_index.rate	196
abstract_inverted_index.same	336
abstract_inverted_index.seen	450
abstract_inverted_index.that	271
abstract_inverted_index.this	48, 57, 66, 75, 84, 93, 102, 112, 353, 563, 570, 577, 584, 591, 598, 605, 612
abstract_inverted_index.time	349, 455
abstract_inverted_index.were	235, 242, 254, 272, 279, 299, 357, 397, 405, 434
abstract_inverted_index.with	224
abstract_inverted_index.(AS).	188
abstract_inverted_index.(mean	339
abstract_inverted_index.(n=2)	417
abstract_inverted_index.(n=8)	387
abstract_inverted_index.(n=9)	404, 421
abstract_inverted_index.12-18	245
abstract_inverted_index.62.1,	341
abstract_inverted_index.Barsa	53, 566
abstract_inverted_index.Grade	226
abstract_inverted_index.Group	227
abstract_inverted_index.Jorge	37, 96, 600
abstract_inverted_index.Kwan,	32
abstract_inverted_index.Lorna	31, 69, 579
abstract_inverted_index.Marks	41, 108, 608
abstract_inverted_index.Rajiv	25, 42, 558
abstract_inverted_index.Sites	270
abstract_inverted_index.Steve	33, 78, 586
abstract_inverted_index.TUMOR	18
abstract_inverted_index.Zhang	62, 573
abstract_inverted_index.Zhou,	34
abstract_inverted_index.both.	419
abstract_inverted_index.every	244
abstract_inverted_index.found	358, 445
abstract_inverted_index.known	440
abstract_inverted_index.large	215, 475
abstract_inverted_index.least	323, 365
abstract_inverted_index.newly	447
abstract_inverted_index.only,	377, 384
abstract_inverted_index.other	180
abstract_inverted_index.prior	277
abstract_inverted_index.sites	151, 438
abstract_inverted_index.start	457
abstract_inverted_index.these	423
abstract_inverted_index.tumor	139, 211
abstract_inverted_index.using	256
abstract_inverted_index.whose	395
abstract_inverted_index.(CaP).	140
abstract_inverted_index.(ROI).	309
abstract_inverted_index.(n=15)	411
abstract_inverted_index.(n=26)	379
abstract_inverted_index.(n=29)	369
abstract_inverted_index.(n=3),	443
abstract_inverted_index.(n=63)	356
abstract_inverted_index.4April	541
abstract_inverted_index.ACTIVE	23
abstract_inverted_index.Active	7
abstract_inverted_index.Author	116
abstract_inverted_index.Ballon	98, 601
abstract_inverted_index.Barsa,	28
abstract_inverted_index.Expand	614
abstract_inverted_index.Haoyue	29, 60, 572
abstract_inverted_index.Median	454
abstract_inverted_index.Serial	484
abstract_inverted_index.Source	513
abstract_inverted_index.Though	160
abstract_inverted_index.Volume	538
abstract_inverted_index.Zhang,	30
abstract_inverted_index.active	186
abstract_inverted_index.appear	425
abstract_inverted_index.author	49, 58, 67, 76, 85, 94, 103, 113, 564, 571, 578, 585, 592, 599, 606, 613
abstract_inverted_index.biopsy	130, 150, 155, 168, 262, 268, 283, 337, 376, 383, 391, 472, 488
abstract_inverted_index.cancer	194, 275
abstract_inverted_index.change	291
abstract_inverted_index.detect	492
abstract_inverted_index.during	152, 185, 266, 334, 489
abstract_inverted_index.either	435
abstract_inverted_index.fusion	154
abstract_inverted_index.future	158
abstract_inverted_index.grants	521
abstract_inverted_index.group,	354
abstract_inverted_index.median	347
abstract_inverted_index.ng/mL,	346
abstract_inverted_index.sample	216
abstract_inverted_index.sites,	169
abstract_inverted_index.sought	190
abstract_inverted_index.system	259
abstract_inverted_index.tumors	176, 442
abstract_inverted_index.types.	392
abstract_inverted_index.within	446
abstract_inverted_index.years.	469
abstract_inverted_index.(MP48)1	10
abstract_inverted_index.Ballon,	38
abstract_inverted_index.Cancer:	5
abstract_inverted_index.Gleason	225
abstract_inverted_index.Leonard	40, 106, 607
abstract_inverted_index.Precise	141
abstract_inverted_index.antigen	344
abstract_inverted_index.between	231
abstract_inverted_index.biopsy,	326, 402, 409
abstract_inverted_index.defined	289
abstract_inverted_index.detects	473
abstract_inverted_index.develop	178
abstract_inverted_index.enabled	144
abstract_inverted_index.months.	246
abstract_inverted_index.offered	236
abstract_inverted_index.recall.	159
abstract_inverted_index.regions	181, 306
abstract_inverted_index.session	338
abstract_inverted_index.site(s)	136
abstract_inverted_index.storage	147
abstract_inverted_index.tracked	198, 330, 375, 497
abstract_inverted_index.tumors,	430
abstract_inverted_index.tumors.	495, 512
abstract_inverted_index.upgrade	466
abstract_inverted_index.years).	351
abstract_inverted_index.201Issue	539
abstract_inverted_index.Abstract	125
abstract_inverted_index.American	531, 550
abstract_inverted_index.Angeles,	527
abstract_inverted_index.CA195505	525
abstract_inverted_index.Danielle	27, 51, 565
abstract_inverted_index.Funding:	515
abstract_inverted_index.METHODS:	221
abstract_inverted_index.Priester	89, 594
abstract_inverted_index.RESULTS:	310
abstract_inverted_index.ToolsAdd	118
abstract_inverted_index.Tracking	129, 471
abstract_inverted_index.additive	502
abstract_inverted_index.articles	46, 55, 64, 73, 82, 91, 100, 110, 561, 568, 575, 582, 589, 596, 603, 610
abstract_inverted_index.biopsies	249, 253, 278, 333, 500
abstract_inverted_index.detected	373, 380, 388, 398, 406, 448
abstract_inverted_index.disease.	367
abstract_inverted_index.greater.	297
abstract_inverted_index.interest	308
abstract_inverted_index.positive	273
abstract_inverted_index.possible	172
abstract_inverted_index.prostate	184, 342
abstract_inverted_index.reviewed	300
abstract_inverted_index.specific	149, 167, 343
abstract_inverted_index.targeted	413
abstract_inverted_index.tracking	161, 282
abstract_inverted_index.upgrades	396, 424
abstract_inverted_index.2019Page:	542
abstract_inverted_index.CA158627,	522
abstract_inverted_index.CA218547,	523
abstract_inverted_index.Copyright	545
abstract_inverted_index.Education	534, 553
abstract_inverted_index.KwanLorna	70
abstract_inverted_index.Priester,	36
abstract_inverted_index.Research,	536, 555
abstract_inverted_index.Supported	516
abstract_inverted_index.TRACKING,	13
abstract_inverted_index.ZhouSteve	79
abstract_inverted_index.ascertain	205
abstract_inverted_index.biopsies,	201
abstract_inverted_index.detection	505
abstract_inverted_index.determine	192
abstract_inverted_index.diagnosed	223
abstract_inverted_index.e697-e697	543
abstract_inverted_index.follow-up	252, 325, 348
abstract_inverted_index.frequency	207
abstract_inverted_index.performed	243, 255, 265
abstract_inverted_index.resampled	280
abstract_inverted_index.sessions.	269
abstract_inverted_index.underwent	321
abstract_inverted_index.upgrading	195, 287, 362, 371, 432, 479, 508
abstract_inverted_index.(Artemis).	260
abstract_inverted_index.Jayadevan*	44, 559
abstract_inverted_index.Localized:	6
abstract_inverted_index.Pathologic	286
abstract_inverted_index.Supplement	540
abstract_inverted_index.Systematic	261
abstract_inverted_index.TARGETING,	14
abstract_inverted_index.UNDERGOING	22
abstract_inverted_index.Urological	532, 551
abstract_inverted_index.containing	465
abstract_inverted_index.diagnostic	318
abstract_inverted_index.electronic	146
abstract_inverted_index.pathologic	361, 478, 507
abstract_inverted_index.percentage	476
abstract_inverted_index.resampling	133, 142
abstract_inverted_index.subsequent	452
abstract_inverted_index.systematic	408, 487
abstract_inverted_index.undergoing	219
abstract_inverted_index.2019MP48-03	12
abstract_inverted_index.Association	533, 552
abstract_inverted_index.BallonJorge	97
abstract_inverted_index.DEVELOPMENT	19
abstract_inverted_index.Information	557
abstract_inverted_index.Jayadevan*,	26
abstract_inverted_index.OBJECTIVES:	128
abstract_inverted_index.ZhangHaoyue	61
abstract_inverted_index.development	212, 303, 461
abstract_inverted_index.non-tracked	200, 332, 382, 401, 499
abstract_inverted_index.CONCLUSIONS:	470
abstract_inverted_index.INTRODUCTION	126
abstract_inverted_index.MarksLeonard	107
abstract_inverted_index.PriesterAlan	88
abstract_inverted_index.SURVEILLANCE	24
abstract_inverted_index.Surveillance	8
abstract_inverted_index.confirmatory	248
abstract_inverted_index.surveillance	165, 187
abstract_inverted_index.Advertisement	544, 616
abstract_inverted_index.BarsaDanielle	52
abstract_inverted_index.Permissions©	547
abstract_inverted_index.accessJournal	2
abstract_inverted_index.contralateral	436
abstract_inverted_index.CitationsTrack	121
abstract_inverted_index.InTwitterEmail	124
abstract_inverted_index.MRI-ultrasound	153
abstract_inverted_index.Jayadevan*Rajiv	43
abstract_inverted_index.Multiparametric	238
abstract_inverted_index.UrologyProstate	4
abstract_inverted_index.downloadLoading	618
abstract_inverted_index.intra-prostatic	138
abstract_inverted_index.Inc.MetricsAuthor	556
abstract_inverted_index.favoritesDownload	120
abstract_inverted_index.ShareFacebookLinked	123
abstract_inverted_index.previously-documented	135
abstract_inverted_index.CitationsPermissionsReprints	122
abstract_inverted_index.Inc.FiguresReferencesRelatedDetails	537
abstract_inverted_index.Informationhttps://doi.org/10.1097/01.JU.0000556473.69506.25AboutPDF	117
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	8
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.06236245
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False